Moheb S Yani1, Sonja J Fenske2, Larissa V Rodriguez3, Jason J Kutch1. 1. Division of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, CA. 2. Neuroscience Graduate Program, University of Southern California, Los Angeles, CA. 3. Department of Urology, University of Southern California, Los Angeles, CA.
Abstract
AIMS: In the human brain, supplementary motor area (SMA) is involved in the control of pelvic floor muscles (PFMs). SMA dysfunction has been implicated in several disorders involving PFMs, including urinary incontinence and urologic pain. Here, we aimed to provide a proof-of-concept study to demonstrate the feasibility of modulating resting PFM activity (tone) as well as SMA activity with noninvasive stimulation of SMA. METHODS: We studied six patients (3 women + 3 men) with Urologic Chronic Pelvic Pain Syndrome. Repetitive transcranial magnetic stimulation (rTMS) was applied to SMA immediately after voiding. We tested two rTMS protocols: high-frequency (HF-rTMS) which is generally excitatory, and low-frequency (LF-rTMS) which is generally inhibitory. PFM activity was measured during rTMS using electromyography. Brain activity was measured immediately before and after rTMS using functional magnetic resonance imaging. RESULTS: The rTMS protocols had significantly different effects on resting activity in PFMs (P = 0.03): HF-rTMS decreased and LF-rTMS increased pelvic floor tone. SMA activity showed a clear trend ( P = 0.06) toward the expected differential changes: HF-rTMS increased and LF-rTMS decreased SMA activity. CONCLUSIONS: We interpret the differential effects of rTMS at the brain and muscle level as novel support for an important inhibitory influence of SMA activity on pelvic floor tone after voiding. This preliminary study provides a framework for designing future studies to determine if neuromodulation of SMA could augment therapy for chronic urologic conditions.
AIMS: In the human brain, supplementary motor area (SMA) is involved in the control of pelvic floor muscles (PFMs). SMA dysfunction has been implicated in several disorders involving PFMs, including urinary incontinence and urologic pain. Here, we aimed to provide a proof-of-concept study to demonstrate the feasibility of modulating resting PFM activity (tone) as well as SMA activity with noninvasive stimulation of SMA. METHODS: We studied six patients (3 women + 3 men) with Urologic Chronic Pelvic Pain Syndrome. Repetitive transcranial magnetic stimulation (rTMS) was applied to SMA immediately after voiding. We tested two rTMS protocols: high-frequency (HF-rTMS) which is generally excitatory, and low-frequency (LF-rTMS) which is generally inhibitory. PFM activity was measured during rTMS using electromyography. Brain activity was measured immediately before and after rTMS using functional magnetic resonance imaging. RESULTS: The rTMS protocols had significantly different effects on resting activity in PFMs (P = 0.03): HF-rTMS decreased and LF-rTMS increased pelvic floor tone. SMA activity showed a clear trend ( P = 0.06) toward the expected differential changes: HF-rTMS increased and LF-rTMS decreased SMA activity. CONCLUSIONS: We interpret the differential effects of rTMS at the brain and muscle level as novel support for an important inhibitory influence of SMA activity on pelvic floor tone after voiding. This preliminary study provides a framework for designing future studies to determine if neuromodulation of SMA could augment therapy for chronic urologic conditions.
Authors: Andrew T Drysdale; Logan Grosenick; Jonathan Downar; Katharine Dunlop; Farrokh Mansouri; Yue Meng; Robert N Fetcho; Benjamin Zebley; Desmond J Oathes; Amit Etkin; Alan F Schatzberg; Keith Sudheimer; Jennifer Keller; Helen S Mayberg; Faith M Gunning; George S Alexopoulos; Michael D Fox; Alvaro Pascual-Leone; Henning U Voss; B J Casey; Marc J Dubin; Conor Liston Journal: Nat Med Date: 2016-12-05 Impact factor: 53.440
Authors: Andrew Schrepf; David A Williams; Robert Gallop; Bruce D Naliboff; Neil Basu; Chelsea Kaplan; Daniel E Harper; J Richard Landis; J Quentin Clemens; Eric Strachan; James W Griffith; Niloofar Afari; Afton Hassett; Michel A Pontari; Daniel J Clauw; Steven E Harte Journal: Pain Date: 2018-10 Impact factor: 6.961
Authors: Jason J Kutch; Moheb S Yani; Skulpan Asavasopon; Daniel J Kirages; Manku Rana; Louise Cosand; Jennifer S Labus; Lisa A Kilpatrick; Cody Ashe-McNalley; Melissa A Farmer; Kevin A Johnson; Timothy J Ness; Georg Deutsch; Richard E Harris; A Vania Apkarian; Daniel J Clauw; Sean C Mackey; Chris Mullins; Emeran A Mayer Journal: Neuroimage Clin Date: 2015-06-05 Impact factor: 4.881
Authors: Max M Klein; Roi Treister; Tommi Raij; Alvaro Pascual-Leone; Lawrence Park; Turo Nurmikko; Fred Lenz; Jean-Pascal Lefaucheur; Magdalena Lang; Mark Hallett; Michael Fox; Merit Cudkowicz; Ann Costello; Daniel B Carr; Samar S Ayache; Anne Louise Oaklander Journal: Pain Date: 2015-09 Impact factor: 7.926
Authors: Moheb S Yani; Joyce H Wondolowski; Sandrah P Eckel; Kornelia Kulig; Beth E Fisher; James E Gordon; Jason J Kutch Journal: Sci Rep Date: 2018-05-08 Impact factor: 4.379
Authors: Ishtiaq Mawla; Andrew Schrepf; Eric Ichesco; Steven E Harte; David J Klumpp; James W Griffith; Eric Strachan; Claire C Yang; Henry Lai; Gerald Andriole; Vincent A Magnotta; Karl Kreder; Daniel J Clauw; Richard E Harris; J Quentin Clemens; J Richard Landis; Chris Mullins; Larissa V Rodriguez; Emeran A Mayer; Jason J Kutch Journal: Sci Rep Date: 2020-11-16 Impact factor: 4.379